1574110-35-2

Upstream product

• 1574117-18-2 1-benzyl-3-(4-chlorophenyl)-4-methyl-5-(trifluoromethyl)-1H-pyrrole-2-carboxylic acid 
• 202198-18-3 N-methyl-N-(2-methanesulphonylethyl)-amine 
• 1574117-14-8 ethyl 1-benzyl-3-(4-chlorophenyl)-4-methyl-1H-pyrrole-2-carboxylate 
• 126760-74-5 ethyl 3-(4-chlorophenyl)-4-methyl-1H-pyrrole-2-carboxylate 
• 37629-52-0 (E)-1-(4-chlorophenyl)-2-nitropropene 
• 104-88-1 4-chlorobenzaldehyde 
• 1574117-15-9 1-benzyl-3-(4-chlorophenyl)-4-methyl-1H-pyrrole-2-carboxylic acid 

Relevant academic research and scientific papers

FLUOROMETHYL-SUBSTITUTED PYRROLE CARBOXAMIDES

The invention relates to pyrrole carboxamides bearing a fluoromethyl- moiety as voltage gated calcium channel blockers, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.

FLUOROMETHYL-SUBSTITUTED PYRROLE CARBOXAMIDES

The invention relates to pyrrole carboxamides bearing a fluoromethyl-moiety as voltage gated calcium channel blockers, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.